Search results
Decoding Moderna Inc (MRNA): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 9 hours agoHowever, the company's strengths, including its robust mRNA technology platform and extensive...
Director AFEYAN NOUBAR sale 15,000 shares of Moderna Inc [MRNA] – Knox Daily
Knox Daily· 14 hours agoGenuity has initiated its “Hold” rating for MRNA. Earlier on November 03, 2023, HSBC Securities upgraded its rating. Their new recommendation was “a Hold” for MRNA ...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 2 days agoModerna, Inc. MRNA reported earnings of $3.07 per share in the first quarter of 2024, beating the...
Moderna (MRNA) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 days agoModerna (MRNA) delivered earnings and revenue surprises of 14.48% and 33.88%, respectively, for the...
mRNA Is Promising A Breakthrough In Fighting Cancer
Benzinga via Yahoo Finance· 5 days agoWhen it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 5 days agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 2 days agoModerna (NASDAQ: MRNA) was a fine stock to heal an ailing portfolio on the second-to-last trading day of the week. The company, which developed and sells...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoI'll now turn the call over to Stephane. Should you invest $1,000 in Moderna right now? Before you buy stock in Moderna, consider this: The Motley Fool ...
Why Earnings Season Could Be Great for Moderna (MRNA)
Zacks· 3 days agoThis suggests that analysts have very recently bumped up their estimates for MRNA, giving the stock a Zacks Earnings ESP of +0.99% heading into earnings ...
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 2 days agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.